Liver Cancer Trial, Recruiting NCT07399236 Sponsor: Tongji Hospital Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT07399236
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 18 and 75 years old, of any gender
  • People who have been diagnosed with colon or rectal cancer (specifically a type called adenocarcinoma), confirmed through laboratory testing of tissue
  • People who have had surgery to fully remove their colorectal cancer, with the goal of curing the disease (known as R0 resection, meaning no cancer was left behind)
  • People who had a detailed CT scan of the abdomen and pelvis with contrast dye performed within one month before their surgery, with clear enough image quality for the study
  • People who showed no signs of cancer having spread to other parts of the body (including the liver) before or during surgery

Who may not be able to join:

  • People who have a history of any other type of cancer
  • People who have previously had liver surgery or a liver transplant
  • People whose medical, imaging, or pathology records are incomplete or unavailable for the study
  • People who passed away within 30 days after their surgery
  • People for whom regular follow-up health information is not available

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 13636076910

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Tongji Hospital
Registry
ClinicalTrials.gov
Start date
1 January 2015
Est. completion
30 January 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Area Under the Receiver Operating Characteristic Curve (AUC)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov